# Highwoods Properties, Inc.: financial statements, quarterly

HIW · NYSE · CIK 921082 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hiw.md) · [Financials](/companies/hiw/financials.md) · [Filings](/companies/hiw/filings.md) · [Insiders](/companies/hiw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hiw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [207](/filings/0000921082-24-000029.md) | [207](/filings/0000921082-24-000033.md) | [207 d](/filings/0000921082-26-000005.md) | [211](/filings/0000921082-25-000021.md) | [205](/filings/0000921082-25-000037.md) | [204](/filings/0000921082-25-000044.md) | [206 d](/filings/0000921082-26-000005.md) | [200](/filings/0000921082-26-000035.md) | [201](/filings/0000921082-25-000037.md) | [202](/filings/0000921082-25-000044.md) | [203 d](/filings/0000921082-26-000005.md) | [214](/filings/0000921082-26-000035.md) |
| Operating income | $m | [141](/filings/0000921082-24-000029.md) | [140](/filings/0000921082-24-000033.md) | [137 d](/filings/0000921082-26-000005.md) | [141](/filings/0000921082-25-000021.md) | [140](/filings/0000921082-25-000037.md) | [139](/filings/0000921082-25-000044.md) | [134 d](/filings/0000921082-26-000005.md) | [135](/filings/0000921082-26-000035.md) | [137](/filings/0000921082-25-000037.md) | [136](/filings/0000921082-25-000044.md) | [137 d](/filings/0000921082-26-000005.md) | [143](/filings/0000921082-26-000035.md) |
| Interest expense | $m | [34.1](/filings/0000921082-24-000029.md) | [34.2](/filings/0000921082-24-000033.md) | [35.3 d](/filings/0000921082-26-000005.md) | [36.6](/filings/0000921082-25-000021.md) | [35.9](/filings/0000921082-25-000037.md) | [37.5](/filings/0000921082-25-000044.md) | [37.3 d](/filings/0000921082-26-000005.md) | [36.6](/filings/0000921082-26-000035.md) | [37.7](/filings/0000921082-25-000037.md) | [38.5](/filings/0000921082-25-000044.md) | [39.7 d](/filings/0000921082-26-000005.md) | [41.7](/filings/0000921082-26-000035.md) |
| Net income | $m | [43.9](/filings/0000921082-24-000029.md) | [23.2](/filings/0000921082-24-000033.md) | [39.3 d](/filings/0000921082-26-000005.md) | [27.2](/filings/0000921082-25-000021.md) | [64.8](/filings/0000921082-25-000037.md) | [15.5](/filings/0000921082-25-000044.md) | [(3.2) d](/filings/0000921082-26-000005.md) | [100](/filings/0000921082-26-000035.md) | [19.2](/filings/0000921082-25-000037.md) | [13.7](/filings/0000921082-25-000044.md) | [29.7 d](/filings/0000921082-26-000005.md) | [33.4](/filings/0000921082-26-000035.md) |
| Diluted EPS | $ per share | [0.40](/filings/0000921082-24-000029.md) | [0.21](/filings/0000921082-24-000033.md) | not reported | [0.25](/filings/0000921082-25-000021.md) | [0.59](/filings/0000921082-25-000037.md) | [0.14](/filings/0000921082-25-000044.md) | not reported | [0.91](/filings/0000921082-26-000035.md) | [0.17](/filings/0000921082-25-000037.md) | [0.12](/filings/0000921082-25-000044.md) | not reported | [0.29](/filings/0000921082-26-000035.md) |
| Basic EPS | $ per share | [0.40](/filings/0000921082-24-000029.md) | [0.21](/filings/0000921082-24-000033.md) | not reported | [0.25](/filings/0000921082-25-000021.md) | [0.59](/filings/0000921082-25-000037.md) | [0.14](/filings/0000921082-25-000044.md) | not reported | [0.91](/filings/0000921082-26-000035.md) | [0.17](/filings/0000921082-25-000037.md) | [0.12](/filings/0000921082-25-000044.md) | not reported | [0.29](/filings/0000921082-26-000035.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [17.0](/filings/0000921082-24-000029.md) | [16.9](/filings/0000921082-24-000033.md) | [25.1](/filings/0000921082-26-000005.md) | [16.4](/filings/0000921082-25-000021.md) | [27.0](/filings/0000921082-25-000037.md) | [23.7](/filings/0000921082-25-000044.md) | [22.4](/filings/0000921082-26-000005.md) | [20.1](/filings/0000921082-26-000035.md) | [21.2](/filings/0000921082-25-000037.md) | [26.3](/filings/0000921082-25-000044.md) | [27.4](/filings/0000921082-26-000035.md) | [32.4](/filings/0000921082-26-000035.md) |
| Total assets | $m | [6,028](/filings/0000921082-23-000050.md) | [6,024](/filings/0000921082-23-000053.md) | [6,003](/filings/0000921082-25-000004.md) | [6,013](/filings/0000921082-24-000020.md) | [5,971](/filings/0000921082-24-000029.md) | [6,028](/filings/0000921082-24-000033.md) | [6,029](/filings/0000921082-26-000005.md) | [6,075](/filings/0000921082-25-000021.md) | [6,059](/filings/0000921082-25-000037.md) | [6,139](/filings/0000921082-25-000044.md) | [6,274](/filings/0000921082-26-000035.md) | [6,597](/filings/0000921082-26-000035.md) |
| Total liabilities | $m | [3,496](/filings/0000921082-23-000050.md) | [3,523](/filings/0000921082-23-000053.md) | [3,515](/filings/0000921082-25-000004.md) | [3,550](/filings/0000921082-24-000020.md) | [3,496](/filings/0000921082-24-000029.md) | [3,591](/filings/0000921082-24-000033.md) | [3,598](/filings/0000921082-26-000005.md) | [3,596](/filings/0000921082-25-000021.md) | [3,616](/filings/0000921082-25-000037.md) | [3,689](/filings/0000921082-25-000044.md) | [3,838](/filings/0000921082-26-000035.md) | [3,983](/filings/0000921082-26-000035.md) |
| Shareholders' equity | $m | [2,471](/filings/0000921082-23-000050.md) | [2,453](/filings/0000921082-23-000053.md) | [2,433](/filings/0000921082-25-000004.md) | [2,403](/filings/0000921082-24-000020.md) | [2,414](/filings/0000921082-24-000029.md) | [2,361](/filings/0000921082-24-000033.md) | [2,361](/filings/0000921082-26-000005.md) | [2,411](/filings/0000921082-25-000021.md) | [2,372](/filings/0000921082-25-000037.md) | [2,382](/filings/0000921082-25-000044.md) | [2,379](/filings/0000921082-26-000035.md) | [2,369](/filings/0000921082-26-000035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [115 d](/filings/0000921082-24-000029.md) | [103 d](/filings/0000921082-24-000033.md) | [103 d](/filings/0000921082-26-000005.md) | [72.4](/filings/0000921082-25-000021.md) | [130 d](/filings/0000921082-25-000037.md) | [97.5 d](/filings/0000921082-25-000044.md) | [104 d](/filings/0000921082-26-000005.md) | [46.3](/filings/0000921082-26-000035.md) | [117 d](/filings/0000921082-25-000037.md) | [96.7 d](/filings/0000921082-25-000044.md) | [99.7 d](/filings/0000921082-26-000005.md) | [62.8](/filings/0000921082-26-000035.md) |
| Dividends paid | $m | [52.7 d](/filings/0000921082-24-000029.md) | [52.8 d](/filings/0000921082-24-000033.md) | [52.8 d](/filings/0000921082-26-000005.md) | [52.9](/filings/0000921082-25-000021.md) | [53.0 d](/filings/0000921082-25-000037.md) | [53.0 d](/filings/0000921082-25-000044.md) | [53.5 d](/filings/0000921082-26-000005.md) | [53.8](/filings/0000921082-26-000035.md) | [53.9 d](/filings/0000921082-25-000037.md) | [54.0 d](/filings/0000921082-25-000044.md) | [55.0 d](/filings/0000921082-26-000005.md) | [55.0](/filings/0000921082-26-000035.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [108](/filings/0000921082-23-000050.md) | [108](/filings/0000921082-23-000053.md) | [108](/filings/0000921082-24-000020.md) | [108](/filings/0000921082-24-000029.md) | [108](/filings/0000921082-24-000033.md) | [108](/filings/0000921082-25-000021.md) | [108](/filings/0000921082-25-000037.md) | [108](/filings/0000921082-25-000044.md) | [110](/filings/0000921082-26-000035.md) | [110](/filings/0000921082-25-000037.md) | [111](/filings/0000921082-25-000044.md) | [112](/filings/0000921082-26-000035.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 110,272,697 at 2026-04-21, from the cover of the [10-Q filed 2026-04-28](/filings/0000921082-26-000035.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 17:21 ET. No prices; not investment advice.